Human Stem-Cell Heart Cells Reset Their Rhythm Like Clocks, Offering a Model for Arrhythmias and Transplant Risks

A single flash on a ball of heart cells shifts the timing of every beat after it
Researchers measured how one light pulse resets beating human stem-cell-derived heart cell spheroids.
Mark

Why does a flash on kidney cells tell us anything about hearts?

Mimi

The kidney spheroid is just a light-sensitive relay. Its current spreads into the beating heart-cell spheroid, so the team could deliver a gentle, repeatable stimulus and measure how the next beat shifted.

Mark

And the result is a phase response curve.

Mimi

Yes, the first one measured directly in human cardiac tissue, according to the authors. Before, models borrowed curves from animals or theory.

Luke

Worth noting it comes from six spheroid pairs, and the spontaneous rate drifted about 18.5 percent during the hour-plus recordings. That's a small, variable sample.

Mark

What about the patient side?

Mimi

They started with 53 Holter patients, narrowed to 40 with consistent PVC shape, then 7 showing cycling coupling intervals. The model with conduction delay reproduced those rhythms.

Luke

Seven people, selected because they looked parasystolic. That shows the model can fit such cases, not that it explains frequent PVCs generally.

Mark

And the transplant link?

Mimi

Engraftment arrhythmias in large animals appear within two weeks, and the competing-oscillator picture fits part of them. The authors map phase-locking zones to suggest control strategies.

Luke

Suggest is the word. No strategy has been tested in patients here, and the ionic model is a simulation.

  • Light pulses striking a sphere of human heart cells can shift its next beat, revealing a sharp fault line in the rhythm where delay tips into acceleration.
  • Heart-cell grafts in large animals have produced dangerous rhythm disturbances within two weeks, a warning that clinical trials cannot ignore.
  • Seven patients with frequent extra beats, selected from a long monitoring registry, showed the telltale pattern of two pacemakers fighting for control.
  • Researchers are mapping zones where the graft and the natural pacemaker lock together, searching for ways to steer the heart away from unsafe rhythms.
  • The strategies remain proposals, and the open question is whether these maps can guide graft designs before patients receive them.

In a laboratory dish, small balls of human heart cells grown from stem cells keep their own quiet time, and a researcher's flash of light can nudge that time forward or back. Scientists have now measured this nudging directly in human tissue for the first time, offering a clearer picture of how one beat can ripple into the next. The same reasoning reaches into the clinic, where a few patients' irregular heartbeats appear to follow a similar logic of competing rhythms. As regenerative heart therapies move toward human trials, the findings give physicians and engineers a rhythm-map for anticipating how new cells might one day disturb the heart they are meant to heal.

In a dish, a small ball of human heart cells beats on its own, roughly once every couple of seconds. Researchers paired each one with a second sphere of cells that does not beat but responds to blue light. A brief flash on the second sphere sent a current into its beating partner, and the team watched how the next beat changed. The aim was to measure something never directly captured in human heart tissue: how a single stimulus shifts an oscillation depending on exactly when it arrives in the cycle.

By pacing at many frequencies, the team traced these shifts across six sphere pairs. The curves shared a sharp break, where early nudges barely mattered or lengthened the beat and later ones shortened it. The pattern was more pronounced than in earlier animal studies, and the authors suspect the cells' ion channels contribute a degree of unpredictability near that break. A simple model built on the curves reproduced the locking patterns seen at different pacing rates.

The team then turned to patients with frequent extra heartbeats, drawn from a registry of multi-day recordings. Narrowing the pool to seven people whose extra beats shared a consistent shape, they looked for a rhythm signature called parasystole, where an abnormal pacemaker competes with the heart's natural one. A model built on the measured curves, including a delay in signal conduction, matched the patients' recordings across several rate ratios.

The stakes lie ahead. Beating stem-cell heart grafts are entering clinical trials, and in large animals they have sparked dangerous rhythms within the first two weeks, possibly from the same kind of competition. The authors' phase-locking maps offer a way to anticipate those zones. The strategies they propose are still proposals, but they point toward safer grafts and gentler interventions.

In a dish, a small ball of human heart cells beats on its own, once every couple of seconds. Researchers writing in PLOS Computational Biology paired each of these spheroids, grown from human induced pluripotent stem cells, with a second spheroid made of non-beating human embryonic kidney cells that respond to blue light. A 10-millisecond flash on the kidney-cell spheroid sent a depolarizing current into its beating partner, and the team watched what happened to the next beat.

The goal was to measure something that had never been directly measured in human cardiac tissue: a phase response curve, which shows how a single stimulus shifts the timing of an oscillation depending on where in the cycle it lands. Until now, theoretical work on heart rhythm disorders has leaned on curves taken from animal models or inferred from theory. The researchers recorded electrical activity across each whole spheroid with a voltage-sensitive dye, an all-optical method that avoids the damage of direct electrical stimulation and does not require genetically modifying the heart cells.

By pacing at many frequencies, they sampled the full cycle. Curves came from six spheroid pairs. Spontaneous frequency ranged from 0.33 to 1.26 Hz, with larger spheroids beating more slowly. A full curve took about an hour or longer per spheroid, and over that time the spontaneous rate drifted by about 18.5 percent across the six pairs. The curves shared features: a sharp discontinuity separating cycle lengthening from shortening, with the discontinuity falling between 0.38 and 0.71 of the cycle depending on the spheroid. Early stimuli had negligible effect or lengthened the cycle, and later ones shortened it, with a pronounced hook right after the discontinuity followed by a straight segment. The hook was more marked than in earlier studies of other species. The authors say near the discontinuity a stimulus can either delay or trigger the next beat, possibly reflecting ion channel noise or unrelated noise. A fitted polynomial matched the data with an error of 0.056, and a simple iterative model built on it reproduced the locking patterns seen at different pacing rates.

The team then turned to patients. They used multi-day Holter recordings from 53 people in the British Columbia PVC Registry, each with more than 5 percent premature ventricular complexes. Screening for patients in whom over 80 percent of PVCs shared the same shape left 40. Looking for cycling coupling intervals, a hallmark of parasystole, in which an abnormal pacemaker competes with the sinus node, narrowed it to 7.

For those seven, the researchers built a modulated parasystole model: a sinus pacemaker, an ectopic pacemaker, a refractory period, and sinus beats that reset the ectopic focus according to the measured curve. Ectopic beats are assumed not to reset the sinus node because of a refractory block at the AV node. Crucially, the model includes a conduction delay into and out of the ectopic focus, which the authors say is necessary to reproduce what appears in the clinical recordings. Using the empirical curve also limited the number of free parameters. Simulations matched patient ECG segments at five different ratios of sinus to ectopic cycle length.

The work matters for a therapy now in clinical trials, in which beating stem-cell-derived heart cells are transplanted into damaged hearts. In large animals, dangerous engraftment arrhythmias have appeared within the first two weeks, and ECGs suggest they arise partly from competition between the sinus node and the graft, a situation resembling parasystole. By combining the resetting analysis with an ionic model of stem-cell heart cells across a range of parameters, the authors mapped phase-locking zones and suggest possible strategies to control these rhythms.

Those strategies remain proposals. The next question is whether the phase-locking maps can guide the design of grafts and interventions that reduce the burden of abnormal beats.

Accounting for conduction delay is necessary to reproduce the dynamics observed in clinical recordings.
— Study authors, PLOS Computational Biology
Contattaci Domande frequenti